Remember that Moderna was a total flop beffore Covid19. Which of the VC's investors have profited?
*************
After raising $2.2 billion in an extension to its seventh fund Monday morning, Flagship followed up in the afternoon by confirming that ex-FDA Commissioner Stephen Hahn, M.D., will join the biotech incubator in a chief medical officer role.
Hahn led the FDA through the beginning of the COVID-19 pandemic and made statements that irked scientists, including his comments on convalescent plasma while standing by former President Donald Trump’s side. He faced pressure from all sides: including reported calls from Trump himself to authorize a COVID-19 vaccine or go, and from the public, industry and others urging him to take his time and get it right.
But now, Hahn will head for another high pressure environment: biotech investing. He is now joining Flagship, the venture fund that birthed Moderna, the very company that earned Hahn's nod six months ago.
Under Hahn's watch, the FDA granted emergency use authorization to the company's COVID-19 vaccine just behind a similar OK for Pfizer and BioNTech's jab. Tens of millions of Americans have now received a Moderna shot.
Hahn will help lead Flagship’s nascent Preemptive Medicine and Health Security business. Flagship founder and CEO Noubar Afeyan, Ph.D., is also chairman of Moderna.
*************
After raising $2.2 billion in an extension to its seventh fund Monday morning, Flagship followed up in the afternoon by confirming that ex-FDA Commissioner Stephen Hahn, M.D., will join the biotech incubator in a chief medical officer role.
Hahn led the FDA through the beginning of the COVID-19 pandemic and made statements that irked scientists, including his comments on convalescent plasma while standing by former President Donald Trump’s side. He faced pressure from all sides: including reported calls from Trump himself to authorize a COVID-19 vaccine or go, and from the public, industry and others urging him to take his time and get it right.
But now, Hahn will head for another high pressure environment: biotech investing. He is now joining Flagship, the venture fund that birthed Moderna, the very company that earned Hahn's nod six months ago.
Under Hahn's watch, the FDA granted emergency use authorization to the company's COVID-19 vaccine just behind a similar OK for Pfizer and BioNTech's jab. Tens of millions of Americans have now received a Moderna shot.
Hahn will help lead Flagship’s nascent Preemptive Medicine and Health Security business. Flagship founder and CEO Noubar Afeyan, Ph.D., is also chairman of Moderna.
https://www.fiercebiotech.com/biotech/six-months-after-granting-moderna-covid-19-eua-ex-fda-commish-joins-biotech-s-founding